Chemical name:(Z)-2-[4-(1,2-Diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine
Formula: C26H29NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

TAMOXIFEN-TEVA 20mg – TEVA PHARMACEUTICAL

Tamoxifen-Teva is a medication that contains tamoxifen citrate as its active ingredient. Tamoxifen is a selective estrogen receptor modulator (SERM) used primarily in the treatment of breast cancer. Tamoxifen-Teva is a specific formulation or brand of tamoxifen, and the description provided here is based on general knowledge of tamoxifen citrate. Specific details may vary depending on the formulation.

Composition and Mechanism of Action:

• Active Ingredient: Tamoxifen citrate is the active ingredient in Tamoxifen-Teva.
• Selective Estrogen Receptor Modulator (SERM): Tamoxifen works by selectively blocking estrogen receptors in breast tissue, inhibiting the effects of estrogen. This is particularly important in hormone receptor-positive breast cancers where estrogen promotes cancer cell growth.

Indications:

• Breast Cancer Treatment: Tamoxifen is commonly prescribed for the treatment of hormone receptor-positive breast cancer in both premenopausal and postmenopausal women. It is often used as adjuvant therapy following surgery or other primary treatments.
• Breast Cancer Prevention: In certain cases, Tamoxifen may be used to reduce the risk of developing breast cancer in women with a high risk of the disease.

Dosage and Administration:

• The dosage of Tamoxifen-Teva may vary based on the specific type and stage of breast cancer being treated or, in the case of prevention, individual risk factors. It is typically taken orally in the form of tablets.

Monitoring:

• Regular monitoring, including breast exams and other diagnostic tests, may be recommended during the course of treatment with Tamoxifen-Teva.

Side Effects:

• Common side effects of tamoxifen may include hot flashes, nausea, fatigue, and changes in menstrual periods. Serious side effects, although less common, may include an increased risk of blood clots and uterine cancer.

Contraindications:

• Tamoxifen-Teva is generally contraindicated in individuals with a history of hypersensitivity to tamoxifen, deep vein thrombosis, or pulmonary embolism.

Precautions:

• Tamoxifen should be used with caution in individuals with a history of blood clots, stroke, or certain eye conditions. Regular eye examinations may be recommended.

Patient Counseling:

• Patients prescribed Tamoxifen-Teva should be educated about its proper use, potential side effects, and the importance of regular follow-up appointments with a healthcare provider.

Pregnancy and Breastfeeding:

• Tamoxifen is not intended for use during pregnancy, and women of childbearing age should use effective contraception during treatment. It is not recommended during breastfeeding.

It’s crucial to note that the information provided here is a general overview, and specific details regarding the use of Tamoxifen-Teva should be discussed with a healthcare professional. The medication should be used under the guidance and supervision of a qualified healthcare provider based on the individual’s medical history and specific health needs.